Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Apply
FluMos-v2 with ALFQ
Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step